Phathom Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 37.81 million compared to USD 40.67 million a year ago. Basic loss per share from continuing operations was USD 0.89 compared to USD 1.07 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.35 USD | +0.19% | +0.58% | +13.36% |
05-09 | Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.36% | 606M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.19% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- PHAT Stock
- News Phathom Pharmaceuticals, Inc.
- Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023